NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-054-2008-0-AU-04 Kinase Inhibitors, Composisions Thereof And Method of Use Therewith AU National Stage 2008267081 Issued
NCI E-054-2008-0-PCT-02 Kinase Inhibitors, Composisions Thereof And Method of Use Therewith PCT PCT PCT/US2008/007181 Expired
NCI E-215-2007-0-PCT-02 MicroRNA-181 Family Members Are Involved In The Function Of Liver Cancer Stem Cells Through Beta-catenin Signaling Activation PCT PCT PCT/US2008/007196 Expired
NCI E-215-2007-0-CN-16 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells CN DIV 201610142734.2 Abandoned
NCI E-215-2007-0-CN-08 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells CN National Stage 200880025276.8 Abandoned
NCI E-215-2007-0-CA-07 Methods for Determining Hepatocellular Carcinoma Subtype and Detecting Hepatic Cancer Stem Cells CA National Stage 2690144 Abandoned
NIA E-016-2004-0-US-07 Methods of Inhibiting Proinflammatory Cytokine Expression Using Ghrelin US ORD 11/596,310 Abandoned
NCI E-256-2008-0-US-01 Survival Predictor For Diffuse Large B Cell Lymphoma US 61/059,678 Abandoned
NCI E-194-2008-0-US-01 IMMUNOTOXINS MADE WITH MODIFIED CHOLIX TOXIN AND USES THEREOF US 61/058,872 Abandoned
NCI E-283-2000-0-JP-22 A Chimeric Protein Comprising Non-Toxic Pseudomonas Exotoxin A And Type IV Pilin Sequences JP DIV 2008-14377 Abandoned
NCI E-194-2005-0-US-03 PROBE FOR NUCLEIC ACID SEQUENCING AND METHODS OF USE (Medusa) US National Stage 12/095,973 7871777 Abandoned PDF
NCI E-308-2005-0-US-04 TREATMENT OF VIRAL INFECTIONS US National Stage 12/085,895 Abandoned
NCI E-213-2007-0-PCT-02 Flexible, Polyvalent Antiviral Dendridic Conjugates for the Treatment of HIV/AIDS and Enveloped Viral Infection PCT PCT PCT/US2008/006922 Abandoned
NCI E-259-2008-0-US-01 MATERIALS AND METHODS FOR IDENTIFYING PATIENTS AT HEIGHTEN RISK FOR DEVELOPING HER2+ RELATED BRAIN TUMORS US 61/057,828 Abandoned
NHGRI E-217-2007-0-IL-18 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT IL DIV 268475 Issued
NHGRI E-217-2007-0-CA-11 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT CA DIV 2903133 Issued
NHGRI E-217-2007-0-EP-14 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT EP DIV 16196935.7 Issued
NHGRI E-217-2007-0-DE-20 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT DE EP 16196935.7 Issued
NHGRI E-217-2007-0-FR-21 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT FR EP 16196935.7 Issued
NHGRI E-217-2007-0-GB-22 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT GB EP 16196935.7 Issued
NHGRI E-217-2007-0-IL-12 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT IL DIV 245026 Issued
NHGRI E-217-2007-0-JP-09 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT JP DIV 2014-208695 Issued
NHGRI E-217-2007-0-IL-05 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT IL National Stage 2072-08-20 Issued
NHGRI E-217-2007-0-CA-03 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT CA National Stage 2680842 Issued
NCI E-025-2006-0-US-03 Anti-Viral Griffithsin Compounds, Compositions, and Methods of Use US National Stage 12/095,697 8088729 Issued PDF
NCI E-164-2007-0-PCT-02 PEPTIDE-BASED STAT INHIBITOR PCT PCT PCT/US2008/065352 Expired
NHGRI E-217-2007-0-PCT-02 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT PCT PCT PCT/US2008/006895 Expired
NHGRI E-217-2007-0-EP-19 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT EP DIV 20197500.0 Pending
NHGRI E-217-2007-0-EP-04 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT EP National Stage 08767999.9 Abandoned
NHGRI E-217-2007-0-JP-06 N-ACETYL MANNOSAMINE AS A THERAPEUTIC AGENT JP National Stage 2010-510363 Abandoned
NIAID E-218-2008-0-US-01 A High-Throughput Screen For T-Lymphocyte Antigens Using Proteins Expressed By In-Vitro Transcription By Translation And Coupled To Latex Heads US 61/056,359 Abandoned
NHLBI E-120-2003-2-US-02 METHOD OF INDUCING MEMORY B CELL DEVELOPMENT AND TERMINAL DIFFERENTIATION US DIV 12/126,166 8247228 Issued PDF
NCI E-279-2005-0-US-06 Poly-saccharide-derived Nitric Oxide-releasing Carbon-bound Diazeniumdiolates US National Stage 12/092,184 7928079 Issued PDF
NIAID E-115-2000-0-CN-26 Attenuated Human-Bovine Chimeric Parainfluenza Virus (PIV) Vaccines CN DIV 200810098526.2 Abandoned
CC E-063-2008-0-US-01 DENDRITIC CONJUGATES AND METHODS OF USE US 61/055,328 Abandoned
NIDDK E-324-2004-3-US-02 In Vitro Model For Hepatitis C Virion Production US National Stage 11/664,375 Abandoned
NCI E-182-2008-0-US-01 METHOD OF TREATING PNEUMOCONIOSIS WITH OLIGODEOXYNUCLEOTIDES US 61/055,102 Abandoned
NIAID E-174-2007-0-PCT-02 SUPPRESSION OF ALLERGIC INFLAMMATION BY ASCARIS HEME-BINDING PROTEINS PCT PCT PCT/US2008/006367 Expired
NIAID E-174-2007-0-US-03 Suppression Of Allergic Inflammation By Ascaris Heme-Binding Protein (HBP) US National Stage 12/600,363 Abandoned
NCI E-316-2008-0-US-01 Methods And Systems Using Therapeutic, Diagnostic or Prophylactic Magnetic Agents US 61/054,239 Abandoned
NIAID E-171-2007-2-PCT-01 Adaptive Mutations That Increase The Infectivity Of Hepatitis C Virus JFH1 In Cell Culture PCT PCT COMB PCT/US2008/063982 Abandoned
NIAID E-343-2008-0-US-02 Long-lasting Inhibitors Of Viral Infection US ORD 12/122,643 Abandoned
NCI E-091-2008-0-US-01 METHOD FOR DETECTION AND QUANTIFICATION OF PLK1 EXPRESSION AND ACTIVITY US 61/054,032 Abandoned
NIDCR E-015-2002-1-US-04 Mammalians Sweet And Amino Acid Heterodimeric Taste receptors Comprising T1R3 And T1R1 US CON 12/121,576 7842786 Expired PDF
NCI E-070-2008-0-US-01 BIOMARKERS FOR DETECTING RADIATION EXPOSURE: METHODS AND USES THEREOF US ORD 12/121,208 Abandoned
NCI E-244-1997-3-US-07 Vacuolar-Type (H+)-ATPase-Inhibiting Compounds,and Uses Thereof US DIV 12/120,778 Abandoned
NCI E-262-2008-0-US-01 APOGOSSYPOL ATROPOISOMERS AND METHODS OF PREPARING THEREOF US 61/053,521 Abandoned
NCI E-258-2008-0-US-01 Design And Synthesis Of Aromatecin Derivatives And Their Identification As Topoisomerase 1 Inhibitors And Anti-cancer Agents65107.00.WO US 61/053,338 Abandoned
NCI E-204-2007-0-PCT-02 METHODS OF GLYCOSYLATION AND BIOCONJUGATION PCT PCT PCT/US2008/006248 Expired
NCI E-103-2005-3-US-02 Papillomavirus L2 N-terminal Peptides For The Induction Of Broadly Cross-neutralizing Antibodies US ORD 11/883,495 8404244 Issued PDF